Paradromics gets FDA nod for broader BCI device compatibility

Paradromics received FDA approval to expand compatibility of its investigational brain-computer interface (BCI) system with a broader range of personal computing devices. The clearance widens the potential integration options for the BCI platform, allowing it to work with more standard consumer and enterprise computing hardware.